article thumbnail

STAT+: Brain biopsies on ‘vulnerable’ patients at Mount Sinai set off alarm bells at FDA, documents show

STAT

In March 2020, as Bauman was preparing to undergo the surgery at a Mount Sinai medical facility in midtown Manhattan, he said he was invited to participate in a research study — one only open to patients already committed to undergo DBS at Mount Sinai.

article thumbnail

FDA sends warning letter to KVK-Tech manufacturing facility

European Pharmaceutical Review

The document identified significant violations of current good manufacturing practice (cGMP) regulations for finished pharmaceuticals. Inadequate validation of test methods : KVK-Tech failed to establish and document the accuracy, sensitivity, specificity and reproducibility of test methods.

FDA 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 Important Things To Know About Social Media As A Resource For Pharmacy Residency Recruitment – For Both Candidates And Programs 

IDStewardship

Since the news of virtual Midyear in 2020, many residency programs have created social media accounts, most often on the platform Twitter. Develop a manual or guidance document outlining the goals of the account. This type of document is especially helpful for account management transitions in resident managed accounts.

article thumbnail

Akorn files for Chapter 7 bankruptcy, terminates all employees

Drug Store News

The company went bankrupt in 2020 after a $4.3 billion takeover offer failed, according to a Bloomberg Law report that cited court documents.

article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

FDA 105
article thumbnail

Regulators questioned integrity of Pfizer/BioNTech vaccine, leaked files show

pharmaphorum

In a review of the documents, the BMJ said they showed concerns over unexpectedly low quantities of intact mRNA in batches of the vaccine developed for commercial production. The documentation was not complete and the leaks did not show how the agency’s concerns were satisfied, the BMJ added.

Vaccines 138
article thumbnail

Coronavirus vaccine may have allergy warning in US, says expert

pharmaphorum

FDA reviewers have already concluded that the vaccine is safe and effective in a briefing document ahead of the Vaccines and Related Biological Products Advisory Committee’s meeting. Feature image copyright BioNTech SE 2020, all rights reserved.

Vaccines 103